Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
Recruiting
Observational Study
NSCLC
Lung Cancer (Diagnosis)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 25 (estimated)
- Sponsor
- European Institute of Oncology · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
investigate the molecular differences between primitive lung cancer and the metastatic site.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* patients aged ≥18 years fit enough to tolerate the surgical operation;
* the operative risk is considered low based on respiratory reserve and cardiac assessment;
* the patient has clearly expressed willingness to adhere;
* availability of pathological material for tumor DNA e…
Contacts